| Issue |
Section |
Title |
File |
| No 7-2 (2011) |
Articles |
NONSPECIFIC VAGINITIS: ETIOLOGY, PATHOGENESIS, CLINICAL PICTURE, DIAGNOSIS, AND CURRENT PRINCIPLES OF TREATMENT |
|
| No 6 (2012) |
Articles |
THE EXPEDIENCY OF ANTIBIOTIC PROHYLAXIS DURING CEASAREAN SECTION IN PREGNANT WOMEN AT LOW RISK FOR INFECTION |
|
| No 6 (2012) |
Articles |
MACROMASTIA OF PREGNANCY: CLINICAL CASES OF BILATERAL MASTECTOMY AND A GOOD OUTCOME |
|
| No 8-2 (2012) |
Articles |
EFFICIENCY OF TREATMENT FOR LATENT IRON DEFICIENCY IN PREGNANT WOMEN WITH CHRONIC PYELONEPHRITIS |
|
| No 1 (2013) |
Articles |
SPECIFICATION OF PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS FOR LOWER INFECTIOUS RISK WOMEN UNDERGOING CESAERIAN SECTION |
|
| No 1 (2013) |
Articles |
EFFICIENCY OF USING EXTRACORPOREAL BLOOD PURIFICATION TECHNIQUES AND MEDICAL OZONE IN PLACENTAL INSUFFICIENCY TREATMENT |
|
| No 2 (2013) |
Articles |
ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF NEONATAL RESPIRATORY DISORDERS IN PLACENTAL INSUFFICIENCY |
|
| No 4 (2013) |
Articles |
THE CLINICAL AND MOLECULAR GENETIC RISK FACTORS OF PREMATURE RUPTURE OF MEMBRANES IN PREGNANT WOMEN WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA |
|
| No 3 (2013) |
Articles |
PLACENTAL INSUFFICIENCY IN PREGNANT WOMEN WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA |
|
| No 6 (2013) |
Articles |
THE PREVENTION AND TREATMENT OF NEONATAL INFECTIOUS AND INFLAMMATORY DISEASES CAUSED BY GROUP B STREPTOCOCCUS |
|
| No 8 (2013) |
Articles |
LOCAL AND SYSTEMIC IMMUNE CHANGES IN OPPORTUNISTIC VAGINAL INFECTIONS IN PREGNANT WOMEN |
|
| No 8 (2013) |
Articles |
CLINICAL AND MOLECULAR GENETIC PREDICTORS FOR CONGENITAL INFECTION IN NEONATAL INFANTS WITH INTRAUTERINE GROWTH RETARDATION |
|
| No 10 (2013) |
Articles |
ENDOMETRIAL MORPHOLOGICAL AND IMMUNIHISTOCHEMICAL FEATURES IN UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA AS A BASIS FOR THE DEVELOPMENT OF OBSTETRIC COMPLICATIONS |
|
| No 9 (2013) |
Articles |
RATIONAL COMBINATION THERAPY WITH SIMULTANEOUS OPERATIONS FOR REFRACTORY IMMUNE THROMBOCYTOPENIA AND DURING PREGNANCY |
|
| No 6 (2014) |
Articles |
CHOICE OF A DELIVERY ROUTE AFTER CESAREAN SECTION |
|
| No 6 (2014) |
Articles |
EVIDENCE-BASED MEDICINE PRINCIPLES IN THE DIAGNOSIS AND PREVENTION OF PYOINFLAMMATORY THROMBOEMBOLIC EVENTS IN PUERPERAS: RESULTS OF INTRODUCTION OF NEW PROTOCOLS |
|
| No 1 (2014) |
Articles |
Posterior reversible encephalopathy syndrome (PRES) caused by hypertensive encephalopathy and acute uremia in a parturient: a clinical case |
|
| No 6 (2014) |
Articles |
ANALYSIS OF THE RESULTS OF USING A REAL-TIME POLYMERASE CHAIN REACTION ASSAY FOR THE DIAGNOSIS OF ACUTE RESPIRATORY DISEASES AND INFLUENZA IN PREGNANT WOMEN AND NEONATES IN THE PERIOD OF EPIDEMICS |
|
| No 7 (2014) |
Articles |
A RATING SCALE OF UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA IN PREDICTING OBSTETRIC COMPLICATIONS |
|
| No 8 (2014) |
Articles |
Use of folates in pregnancy |
|
| No 8 (2014) |
Articles |
Molecular genetic predictors of uterine inertia |
|
| No 10 (2014) |
Articles |
Prediction of fetal growth retardation in pregnant women with undifferentiated connective tissue dysplasia |
|
| No 9 (2014) |
Articles |
Diagnostic value of local factors for innate immunity in extremely premature neonates with intrauterine infection |
|
| No 3 (2015) |
Articles |
Placental apoptosis and antioxidant defense enzyme gene expression in preeclampsia |
|
| No 4 (2015) |
Articles |
DIAGNOSTIC ROLE OF THE CLINICAL AND MOLECULAR GENETIC PREDICTORS OF INTRAUTERINE INFECTION |
|
| No 6 (2015) |
Articles |
LOCAL IMMUNITY DURING THERAPY FOR CANDIDA VAGINITIS DURING PREGNANCY |
|
| No 1 (2015) |
Articles |
Specific features of uterine scar formation after cesarean section in undifferentiated connective tissue dysplasia |
|
| No 1 (2015) |
Articles |
Calcium supplements in the prevention of pregnancy complications |
|
| No 6 (2015) |
Articles |
CURRENT APPROACHES TO TREATING PAPILLOMAVIRUS INFECTION |
|
| No 12 (2015) |
Articles |
PATHOGENETIC ASPECTS OF PREECLAMPSIA |
|
| No 11 (2015) |
Articles |
CLINICAL OBSERVATION: PROLONGATION OF PREGNANCY WITH A FAVORABLE OUTCOME IN A PATIENT WITH CRITICAL AORTIC PROSTHETIC THROMBOSIS |
|
| No 12 (2015) |
Articles |
CURRENT PRINCIPLES OF THERAPY FOR PAPILLOMAVIRUS INFECTION |
|
| No 2 (2016) |
Articles |
Significance of detoxification system gene polymorphisms in preeclampsia |
|
| No 4 (2016) |
Articles |
Medically induced abortion at 12 to 22 weeks gestation: Indications, methods, and results |
|
| No 5 (2016) |
Articles |
PRO- AND ANTIOXIDANT SYSTEM IN PRETERM BIRTH |
|
| No 6 (2016) |
Articles |
Prognostic value of a ratio of soluble fms-like tyrokinase1 to placental growth factor in pregnant women with preeclampsia |
|
| No 1 (2016) |
Articles |
SPECIFIC FEATURES OF ANTIOXIDANT DEFENSE IN THE MOTHER-PLACENTA-FETUS SYSTEM IN INTRAUTERINE INFECTION |
|
| No 3 (2016) |
Articles |
AUTOANTIBODIES AGAINST ENDOTHELIAL ANTIGENS IN PREECLAMPSIA |
|
| No 6 (2016) |
Articles |
Clinical and anamnestic risk factors for preeclampsia in pregnant women |
|
| No 5 (2016) |
Articles |
OXIDATIVE STRESS IN PREECLAMPSIA AND IN NORMAL PREGNANCY |
|
| No 8 (2016) |
Articles |
Identification of preeclampsia-related miRNA by a deep sequencing technique and a real-time quantitative PCR |
|
| No 7 (2016) |
Articles |
Somatic tissue chromosomal mosaicism in monozygotic triplets concurrent with early preeclampsia |
|
| No 12 (2016) |
Articles |
QUANTIFICATION OF PLASMA MICRORNA EXPRESSION IN PREGNANT WOMEN WITH PREECLAMPSIA |
|
| No 1 (2017) |
Articles |
PROPHYLAXIS OF EARLY REPRODUCTIVE LOSSES |
|
| No 1 (2017) |
Articles |
DIAGNOSIS AND TREATMENT OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY. CLINICAL RECOMMENDATIONS |
|
| No 4 (2017) |
Articles |
Diagnostic significance of malondialdehyde level and catalase activity evaluation in women with preterm labor |
|
| No 7 (2017) |
Articles |
Perinatal prevention of diseases caused by Group B streptococcus (clinical protocol) |
|
| No 9 (2017) |
Articles |
Pathogenetic mechanisms of placental insufficiency and preeclampsia |
|
| No 10 (2017) |
Articles |
Pregnancy management complicated by intrauterine growth restriction |
|
| No 10 (2017) |
Articles |
Patient-centered care: The vector of development of obstetric hospital |
|
| No 4 (2018) |
Articles |
Integrated approach to preeclampsia prediction based on molecular genetics and clinical factors |
|
| No 3 (2018) |
Articles |
The role of the soluble fms-like tyrosin kinase-1 / the placental growth factor ratio in the diagnostics of preeclampsia in physiological pregnancy and pregnancy after IVF |
|
| No 6 (2018) |
Articles |
The role of E-kadherin in the formation of intrauterine growth restriction |
|
| No 11 (2018) |
Articles |
Diagnostic value of preactivated neutrophils in preeclampsia |
|
| No 12 (2018) |
Articles |
The role of methylentetrahydrofolate reductase (MTHFR) gene polymorphism in intrauterine growth restriction development |
|
| No 11 (2018) |
Articles |
Predicting impairment of pre-lactation transformation and preventing lactogenesis failure in metabolic syndrome |
|
| No 8 (2018) |
Articles |
BACTERIAL VAGINOSIS AND ANTIMICROBIAL ACTIVITY DURING PREGNANCY |
|
| No 8 (2018) |
Articles |
CORRECTION OF IRON-DEFICIENCY ANEMIA IN PREGNANT WOMEN |
|
| No 1 (2019) |
Articles |
Predicting preterm labor by combined testing of cytokines and cell-free DNA |
|
| No 4 (2019) |
Articles |
The role of preeclampsia in pregnancy outcomes: the view of a neonatologist |
|
| No 5 (2019) |
Articles |
The features and efficiency of therapy for uncomplicated cystitis in pregnant women and puerperas |
|
| No 5 (2019) |
Articles |
Late pregnancy termination by a medical technique in combination with cervical osmotic dilators |
|
| No 7 (2019) |
Articles |
Prediction of pre-eclampsia on the couts of CD-16 negative monocytes |
|
| No 11 (2019) |
Articles |
Specific features of a metabolomic profile in preeclampsia |
|
| No 11 (2019) |
Articles |
Role of transforming growth factor-β in the formation of fetal growth restriction |
|
| No 12 (2019) |
Articles |
Gene methylation in the placenta of fetuses with fetal growth restriction |
|
| No 12 (2019) |
Articles |
Metabolomic profile in pregnant women with fetal growth restriction |
|
| No 8 (2019) |
Articles |
DIAGNOSTIC SIGNIFICANCE OF DETERMINING THE LEVEL OF EXTRACELLULAR FETAL DNA IN PREGNANT WOMEN WITH PREECLAMPSIA AND FETAL GROWTH RESTRICTION |
|
| No 6 (2020) |
Articles |
Plasma levels of soluble E-cadherin and the keratinocytes growth factor in intrauterine growth restriction |
|
| No 7 (2020) |
Articles |
Methylation of the TLR2 and IGF2/H19 ICR genes in the placenta and blood plasma in preeclampsia |
|
| No 6 (2020) |
Articles |
Iron deficiency states during pregnancy: prevention and treatment |
|
| No 3S (2021): Supplement |
Articles |
DIAGNOSTIKA, PROFILAKTIKA I TERAPIYa ZhELEZODEFITsITNYKh SOSTOYaNIY U BEREMENNYKh: VZGLYaD AKUShERA-GINEKOLOGA I GEMATOLOGA |
|
| No 3 (2021) |
Articles |
Possibilities of predicting preterm birth using mitochondrial DNA and VDAC1 protein |
|
| No 6 (2021) |
Articles |
Predictive value of testing for maternal plasma cell-free fetal DNA in fetal growth restriction |
|
| No 10 (2021) |
Articles |
Features of changes in the monocyte-macrophage cells in the placenta during preeclampsia |
|
| No 9 (2021) |
Articles |
Association between the level of specific urinary SERPINA1 protein in pregnant women and the severity of preeclampsia and perinatal outcomes |
|
| No 8 (2022) |
Articles |
Fetal growth retardation in the context of fetal programming |
|
| No 8 (2022) |
Articles |
A comprehensive approach to treating chronic recurrent uncomplicated cystitis during pregnancy |
|
| No 5 (2022) |
Articles |
Favorable maternal and perinatal outcomes of pregnancy in a COVID-19 patient with total lung damage |
|
| No 12 (2022) |
Articles |
Epigenetic aspects of the pathogenesis of preeclampsia |
|
| No 11 (2022) |
Articles |
Features of neurogenesis in fetal growth restriction |
|
| No 11 (2022) |
Articles |
Asymptomatic bacteriuria in pregnancy: a modern approach to therapy |
|
| No 1 (2022) |
Articles |
Role of insulin resistance in the mechanisms of adaptation and development of female reproductive system disease |
|
| No 1 (2022) |
Articles |
Prooxidant and antioxidant content in capillary blood in preterm birth |
|
| No 4 (2022) |
Articles |
Preeclampsia as a separate gestational clinical and pathogenetic form of insulin resistance syndrome |
|
| No 2 (2022) |
Articles |
Role of insulin resistance in the mechanisms of adaptation and development of disease in postpartum and early neonatal periods |
|
| No 3 (2023) |
Clinical Notes |
Intra-abdominal hemorrhage in a pregnant woman as a manifestation of endometrioid disease |
|
| No 9 (2020) |
Articles |
Earlyand late-onset fetal growth restriction: differential diagnosis based on proand antioxidant system markers |
|
| No 10 (2016) |
Articles |
LOCAL FACTORS OF INNATE IMMUNITY IN THE PREDICTION OF PRETERM BIRTH |
|
| No 2 (2023) |
Original Articles |
Association between new coronavirus infection and fetal growth restriction |
|
| No 5 (2023) |
Reviews |
Role of mitochondrial dysfunction in the pathogenesis of premature birth |
|
| No 5 (2023) |
Original Articles |
Phenotypic profile of peripheral blood mononuclear cells in preeclampsia |
|
| No 7 (2023) |
Exchange of Experience |
Complex therapy of bacterial vaginosis during pregnancy |
|
| No 8 (2023) |
Original Articles |
Diagnostic significance of determining the expression of energy metabolism genes in fetal growth retardation |
|
| No 9 (2023) |
Original Articles |
Clinical and pathogenetic rationale for two-stage prevention of preeclampsia in high-risk women using an insulin sensitizer for preconception preparation |
|
| No 9 (2023) |
Original Articles |
Clinical and anamnestic factors in the prediction and diagnosis of fetal growth restriction |
|
| No 10 (2023) |
Reviews |
Controversial issues of antenatal glucocorticoid use in fetal growth retardation |
|
| No 10 (2023) |
Reviews |
Modern concepts on the etiology and pathogenesis of premature rupture of membranes |
|
| No 11 (2023) |
Reviews |
Molecular genetic markers in the pathogenesis of fetal growth retardation |
|
| No 11 (2023) |
Exchange of Experience |
Complex therapy of recurrent vulvovaginal candidiasis in pregnancy |
|
| No 3 (2024) |
Guidelines for the Practitioner |
Algorithm for diagnosis and treatment of gastroesophageal reflux disease in pregnant women |
|
| No 4 (2024) |
Reviews |
The concept of epigenetic modifications in fetal metabolic programming |
|
| No 4 (2024) |
Original Articles |
Diagnostic significance of proteome analysis of maternal plasma in fetal growth restriction |
|
| No 4 (2024) |
Original Articles |
Rationale for preoperative treatment of advanced-stage endometrial ovarian cysts in infertile women |
|
| No 4 (2024) |
Guidelines for the Practitioner |
Modern concepts in the treatment of urogenital chlamydia trachomatis infection during pregnancy |
|
| No 5 (2024) |
Original Articles |
Factors of energy metabolism in fetal growth restriction |
|
| No 5 (2024) |
Original Articles |
Prediction of neonatal complications based on quantitative proteome analysisin blood of pregnant women with fetal growth restriction |
|
| No 5 (2024) |
Original Articles |
The influence of dysbiotic disorders and local inflammatory reactions in the reproductive tract on the development of preterm birth |
|
| No 9 (2024) |
Reviews |
Extracellular vesicles as biomarkers of pathology of the fetal central nervous system in placental dysfunction |
|
| No 9 (2024) |
Original Articles |
Correlation of perinatal outcomes in preeclampsia with the dynamics of CD16+ monocyte content in peripheral blood |
|
| No 10 (2024) |
Original Articles |
Clinical and anamnestic risk factors and prediction models for the development of fetal growth restriction |
|
| No 10 (2024) |
Original Articles |
The effect of incretin hormone GLP-1 on the phenotypic profile of mononuclear cells in fetal growth restriction |
|
| No 11 (2024) |
Original Articles |
Markers for fetal growth restriction based on the study of the polymorphism of gene regulatory regions |
|
| No 12 (2024) |
Medicine and Law |
The role of informed consent for medical intervention in the investigation of legal cases against obstetrician-gynecologists |
|
| No 2 (2025) |
Original Articles |
A model for diagnosing fetal growth restriction using functional diagnostic methods |
|
| No 2 (2025) |
Original Articles |
Lipid profile of fetal membrane tissue in premature rupture of membranes |
|
| No 3 (2025) |
Original Articles |
Criteria for assessing fetal neurogenesis dysfunction in early-onset growth restriction using extracellular vesicles |
|
| No 3 (2025) |
Original Articles |
Postnatal development in children with growth restriction (follow-up study) |
|
